| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 5.05e-04 | 24 | 26 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 5.05e-04 | 24 | 26 | 2 | IPR014715 | |
| Domain | Fibrinogen_C | 6.40e-04 | 27 | 26 | 2 | PF00147 | |
| Domain | FBG | 7.39e-04 | 29 | 26 | 2 | SM00186 | |
| Domain | - | 7.91e-04 | 30 | 26 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 7.91e-04 | 30 | 26 | 2 | IPR014716 | |
| Domain | Fibrinogen_a/b/g_C_dom | 9.01e-04 | 32 | 26 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 9.01e-04 | 32 | 26 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 9.01e-04 | 32 | 26 | 2 | PS00514 | |
| Pubmed | 9.70e-05 | 17 | 30 | 2 | 32938586 | ||
| Pubmed | 1.22e-04 | 19 | 30 | 2 | 18206867 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 3.45e-04 | 392 | 30 | 4 | 33144569 | |
| Pubmed | 3.83e-04 | 403 | 30 | 4 | 35253629 | ||
| Pubmed | A critical role for NF2 and the Hippo pathway in branching morphogenesis. | 4.45e-04 | 36 | 30 | 2 | 27480037 | |
| Pubmed | 6.78e-04 | 469 | 30 | 4 | 27634302 | ||
| Interaction | PRB4 interactions | 1.72e-05 | 5 | 27 | 2 | int:PRB4 | |
| Interaction | PCSK4 interactions | 3.61e-05 | 7 | 27 | 2 | int:PCSK4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 3.80e-03 | 140 | 30 | 2 | chr7q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 5.35e-03 | 167 | 30 | 2 | chr1q25 | |
| GeneFamily | Fibrinogen C domain containing | 3.79e-04 | 25 | 21 | 2 | 554 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.59e-06 | 189 | 30 | 4 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| Computational | Breast cancer expression clusters. | 2.43e-04 | 217 | 16 | 4 | MODULE_389 | |
| Disease | kidney cancer (implicated_via_orthology) | 5.10e-05 | 11 | 29 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 36:3 measurement | 9.72e-05 | 15 | 29 | 2 | EFO_0010381 | |
| Disease | Colorectal Neoplasms | 1.50e-04 | 277 | 29 | 4 | C0009404 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 9.40e-04 | 46 | 29 | 2 | EFO_0008003, GO_0097332 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.11e-03 | 50 | 29 | 2 | EFO_0010732 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.17e-03 | 566 | 29 | 4 | EFO_0007660, EFO_0008354 | |
| Disease | cancer (implicated_via_orthology) | 2.27e-03 | 268 | 29 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | beverage consumption measurement | 3.02e-03 | 83 | 29 | 2 | EFO_0010088 | |
| Disease | Ischemic stroke | 3.88e-03 | 324 | 29 | 3 | HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGVWYRGGHYRSKHQ | 451 | O95841 | |
| KEAYKWYELGHKRGH | 541 | Q12797 | |
| WFYIHGVFYHLAKRL | 181 | O60683 | |
| GWLQHDYGHLSVYRK | 176 | O95864 | |
| FRWTHNSKYYQKGSH | 816 | Q9NRM7 | |
| LYQWHRKQYVGAAHG | 251 | Q9NS86 | |
| KGYRKITYHNWRHGF | 551 | P16499 | |
| YFGKGTKQWVHARYA | 176 | P06734 | |
| LRGHLAKIYAMHWGY | 51 | Q9HAV0 | |
| LKIHVAHWYNVRYRG | 236 | Q07864 | |
| KLAYHAYQKWVREHG | 681 | O95672 | |
| NHIWKFRYDRPFHKG | 1411 | Q8N1I0 | |
| FGDYYHFWHRGVTKR | 61 | P09958 | |
| GYKIWHYTGSILHKY | 386 | Q9BY44 | |
| GRWYVYCKTHPRHKQ | 86 | Q9P0J6 | |
| SCYRGHRGYRTKHWS | 146 | A6NNA2 | |
| KKGGRHAAYHRRWFV | 26 | Q8N4B1 | |
| VEKLYFHLHYSRGWG | 291 | B2RXF0 | |
| TTKYYRFLAKHGGWV | 291 | P81133 | |
| RVWLGKHYKKYVHAD | 56 | Q92922 | |
| LSYKWAKISGHHYPY | 176 | P0DPA2 | |
| KYGESRHSQGINWYH | 1311 | Q92752 | |
| GYRNHYKVTALHWAA | 631 | Q6P2S7 | |
| FGHWTYECTGKRKYL | 51 | Q8TBK6 | |
| WGYTLSYRLQKGFKH | 356 | Q5SQS7 | |
| YFGHKYRLIKHWSVH | 386 | Q68DY9 | |
| GYWASHLAGRKYHIS | 1401 | Q9NYU2 | |
| LAYHWRIHTGEKAYK | 416 | P51522 | |
| RYWFALKRGYHAAFK | 91 | Q5GH70 | |
| SKALYSVHWYRQKHG | 46 | A0A087WSZ9 |